Endoscopy 2014; 46(S 01): E427-E428
DOI: 10.1055/s-0034-1377433
Cases and Techniques Library (CTL)
© Georg Thieme Verlag KG Stuttgart · New York

Postgastrectomy protein-losing cytomegalovirus jejunitis in an immunocompromised patient

Philip Roelandt
1   Gastroenterology Department, University Hospitals Leuven, Leuven, Belgium
,
Helene Poels
1   Gastroenterology Department, University Hospitals Leuven, Leuven, Belgium
,
Ester Meeus
2   Pathology Department, University Hospitals Leuven, Leuven, Belgium
,
Eric Van Cutsem
3   Digestive Oncology Department, University Hospitals Leuven, Leuven, Belgium
,
Hans Prenen
3   Digestive Oncology Department, University Hospitals Leuven, Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Publication Date:
14 October 2014 (online)

A 59-year-old man was admitted because of nausea and fatigue. He had been diagnosed with gastric adenocarcinoma 7 months earlier, and because of gastric outlet obstruction had undergone total gastrectomy with esophagojejunostomy and omentectomy (pT3N3bM0R1). Postoperatively, platinum-based chemotherapy was initiated, followed by radiochemotherapy (5-fluorouracil + 45 Gy) approximately 2 weeks before admission.

Initially, the nausea and fatigue were attributed to ongoing radiochemotherapy. During admission the patient became bedbound, with pronounced anasarca edema secondary to severe hypoalbuminemia (lowest level 9.9 g/L, normal 35 – 52 g/L) despite maximal supportive care, suggestive of protein-losing enteropathy (proteinuria was only mild). From the esophagojejunostomy onwards, the mucosa was severely inflamed with ulcerations, desquamation, and spontaneous submucosal hemorrhages for approximately 15 cm in the jejunum ([Fig. 1 a, b]). Microscopic examination revealed extensive ulceration with granulation and dense infiltration of mononuclear cells, cytomegaly, and Cowdry inclusions ([Fig. 1 c]). The diagnosis of cytomegalovirus (CMV) jejunitis was strengthened by positive serum CMV polymerase chain reaction (PCR; 3.84 log copies/mL). After 2 weeks of treatment with ganciclovir, the patient’s general condition recovered and CMV PCR became negative. At 1 month after discharge, the patient was in good general condition with an albumin level of 31.2 g/L ([Fig. 1 d]).

Fig. 1 Cytomegalovirus jejunitis in an immunocompromised patient. a, b Upper gastrointestinal endoscopy revealed inflamed mucosa from the esophagojejunostomy, followed by ulcerative jejunitis with spontaneous submucosal hemorrhages. c Hematoxylin and eosin staining showed cytomegaly (arrow heads) and Cowdry inclusion body (arrow), with specific cytomegalovirus staining positive (insert). d Serum albumin levels over time. Green bar indicates treatment period with ganciclovir.

Zoom Image
Zoom Image
Zoom Image
Zoom Image

Although CMV infection is mostly asymptomatic or gives rise to only mild mononucleosis-like symptoms, in immunocompromised or critically ill patients it can cause life-threatening complications [1] [2] [3]. CMV enteritis occurs in only 4 % of patients with CMV disease and is mostly restricted to a defined area rather than being panenteric [4]. As shown in inflammatory bowel diseases where CMV infects areas of already inflamed mucosa [5], it is likely that mucosal changes secondary to radiotherapy provide favorable conditions for CMV infection. The protein-losing enteropathy was most likely a combination of inflammatory exudation and villous atrophy with increased permeability associated with CMV infection [6].

This case illustrates that CMV should be included in the differential diagnosis of protein-losing enteropathy, especially following radiation therapy, and that biopsies should be taken to investigate CMV even when other potential explanations of mucositis are present.

Endoscopy_UCTN_Code_CCL_1AC_2AH

 
  • References

  • 1 Whitley RJ, Jacobson MA, Friedberg DN et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society – USA. Arch Intern Med 1998; 158: 957-969
  • 2 Chamberlain RS, Atkins S, Saini N et al. Ileal perforation caused by cytomegalovirus infection in a critically ill adult. J Clin Gastroenterol 2000; 30: 432-435
  • 3 Jain M, Duggal S, Chugh TD. Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries 2011; 5: 571-579
  • 4 Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep 2008; 10: 409-416
  • 5 Kaufman HS, Kahn AC, Iacobuzio-Donahue C et al. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999; 42: 24-30
  • 6 Nakase H, Itani T, Mimura J et al. Transient protein-losing enteropathy associated with cytomegalovirus infection in a noncompromised host: a case report. Am J Gastroenterol 1998; 93: 1005-1006